NEXT Oncology — Austin, Texas

NEXT Oncology is a clinical research site located in Austin, Texas, United States 78758.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

NEXT Oncology has participated in 32 clinical trials with 13 currently active.

Therapeutic areas: RAS Mutation, NF1 Mutation, RAF Mutation.

Sponsors: Pasithea Therapeutics Corp., Merck Sharp & Dohme LLC, Kura Oncology, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Austin

Browse all research sites in Texas · View every site in Austin

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Oncology?

NEXT Oncology has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Oncology conducted?

NEXT Oncology has 32 clinical trials on record, with 13 currently active. Their work covers RAS Mutation, NF1 Mutation, RAF Mutation.

Is NEXT Oncology accredited by Crixeo Clinical Trials?

NEXT Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NEXT Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.